03 June 1998
Roslin Bio-Med gets Best
ROSLIN Bio-Med, the company established to further develop the technology used to create Dolly the cloned sheep, has appointed Simon Best as chief executive officer.
Best, 41, was previously chief executive officer and managing director of Zeneca Plant Science which is developing genetically modified foods.
- Financial Times 03/06/98 page 15 (People on the Move)